BDBM50210073 CHEMBL3883461

SMILES Cc1nc(N)cc2OCC\C=C/CCCOc3cc(Cn4cccn4)ccc3Cn3cc(cn3)C(=O)NCc12

InChI Key InChIKey=ZVYLYYBRLJOHMS-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50210073   

TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 4.09E+4nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 42nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2nMAssay Description:Inhibition of human plasma kallikrein incubated for 1 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 3.60E+3nMAssay Description:Inhibition of human fXIIa incubated for 1 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed